Available now: Open-access interviews with experts on the COVID-19 pandemic: epidemiology, virus biology and possible vaccines and treatmentsView All
Dr. Anne Pariser National Institutes of Health, USA2 Talks
Anne Pariser is the director of the Office of Rare Diseases Research (ORDR) at the National Center for Advancing Translational Sciences (NCATS), NIH. ORDR is dedicated to accelerating rare diseases research to benefit patients through rare diseases programs such as the Rare Diseases Clinical Research Network, Genetic and Rare Diseases... read moreInformation Center (GARD), and the NCATS Toolkit for Patient-focused Therapy Development. Important translational science research initiatives for rare diseases at ORDR include establishing best practices and tools for good quality natural history studies, data standards and sharing initiatives, and the development of diagnostic support tools, in addition to translational and basic science research grants and collaborative programs. Before come to NCASTs in 2017, Dr. Pariser worked for 16 years at the US Food and Drug Administration Center for Drug Evaluation and Research, where she founded the Rare Diseases Program in FDA CDER’s Office of New Drugs in 2010 and served as a Medical Officer and Team Leader for rare diseases drug and biologics product development, review and regulation. Dr. Pariser has almost 20 years experience in rare diseases research, and her current research interests include platform approaches for gene therapies and other rare disease product development, and informatics approaches for diagnosis.